AAAAAA

   
Results: 1-7 |
Results: 7
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome
Authors: Somlo, G Doroshow, JH Synold, T Longmate, J Reardon, D Chow, W Forman, SJ Leong, LA Margolin, KA Morgan, RJ Raschko, JW Shibata, SI Tetef, ML Yen, Y Kogut, N Schriber, J Alvarnas, J
Citation: G. Somlo et al., High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome, BR J CANC, 84(12), 2001, pp. 1591-1598
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
Authors: Stein, AS O'Donnell, MR Slovak, ML Nademanee, A Dagis, A Schmidt, GM Parker, PM Snyder, DS Smith, EP Somlo, G Margolin, KA Arber, D Niland, J Forman, SJ
Citation: As. Stein et al., High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission, LEUKEMIA, 14(7), 2000, pp. 1191-1196
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A
Authors: Raschko, JW Synold, TW Chow, W Coluzzi, P Hamasaki, V Leong, LA Margolin, KA Morgan, RJ Shibata, SI Somlo, G Tetef, ML Yen, Y ter Veer, A Doroshow, JH
Citation: Jw. Raschko et al., A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A, CANC CHEMOT, 46(5), 2000, pp. 403-410
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in thetreatment of leptomeningeal carcinomatosis
Authors: Tetef, ML Margolin, KA Doroshow, JH Akman, S Leong, LA Morgan, RJ Raschko, JW Slatkin, N Somlo, G Longmate, JA Carroll, MI Newman, EM
Citation: Ml. Tetef et al., Pharmacokinetics and toxicity of high-dose intravenous methotrexate in thetreatment of leptomeningeal carcinomatosis, CANC CHEMOT, 46(1), 2000, pp. 19-26
Interleukin-2 in the treatment of renal cancer
Authors: Margolin, KA
Citation: Ka. Margolin, Interleukin-2 in the treatment of renal cancer, SEMIN ONCOL, 27(2), 2000, pp. 194-203
Melanoma and other cutaneous malignancies
Authors: Sondak, VK Margolin, KA
Citation: Vk. Sondak et Ka. Margolin, Melanoma and other cutaneous malignancies, SURGERY: BASIC SCIENCE AND CLINICAL EVIDENCE, 2000, pp. 1733-1752
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial
Authors: Margolin, KA Liu, PY Unger, JM Fletcher, WS Flaherty, LE Urba, WJ Hersh, EM Hutchins, LE Sosman, JA Smith, JW Weiss, GR Sondak, VK
Citation: Ka. Margolin et al., Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial, J CANC RES, 125(5), 1999, pp. 292-296
Risultati: 1-7 |